Literature DB >> 2316766

Epidemiologic and clinical characteristics of persons with serologic evidence of E. canis infection.

B W Rohrbach1, J R Harkess, S A Ewing, J Kudlac, G L McKee, G R Istre.   

Abstract

The results of a serosurvey of Oklahomans for the presence of antibody to Ehrlichia canis is reported. Paired serum specimens, from patients lacking the serologic criteria for diagnosis of Rocky Mountain spotted fever (RMSF), were tested. A four-fold increase in E. canis-IFA antibody was found in 16/144 (11 percent) of these paired serum samples. Patients with serologic evidence of E. canis infection had a mean age of 34 years, 69 percent were male, and 63 percent lived in a town less than 10,000 population. Signs and symptoms included: fever 94 percent, headache 94 percent, fatigue 94 percent, anorexia 81 percent, nausea 60 percent, and rash 44 percent. When compared to control patients, whose sera were submitted for RMSF testing but did not meet serologic criteria for RMSF or E. canis, case-patients were more likely to have had leukopenia (OR = 4.9, 95 percent Cl = 1.2, 19.0) and tick exposure (OR = 9.5, 95 percent Cl = 1.4, 62.7). The results suggest E. canis, or a closely related agent, is a cause of human illness. Ticks are probable vector.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316766      PMCID: PMC1404562          DOI: 10.2105/ajph.80.4.442

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  Ehrlichiosis: a cause of bone marrow hypoplasia in humans.

Authors:  C J Pearce; M E Conrad; P E Nolan; D B Fishbein; J E Dawson
Journal:  Am J Hematol       Date:  1988-05       Impact factor: 10.047

2.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

3.  Serological evidence of possible human infection with Ehrlichia in Texas.

Authors:  J P Taylor; T G Betz; D B Fishbein; M A Roberts; J Dawson; M Ristic
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

4.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

5.  Distribution of Ehrlichia canis among military working dogs in the world and selected civilian dogs in the United States.

Authors:  T J Keefe; C J Holland; P E Salyer; M Ristic
Journal:  J Am Vet Med Assoc       Date:  1982-08-01       Impact factor: 1.936

6.  Clinical and hematologic findings in canine ehrlichiosis.

Authors:  N F Kuehn; S D Gaunt
Journal:  J Am Vet Med Assoc       Date:  1985-02-15       Impact factor: 1.936

7.  Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus.

Authors:  R N Philip; E A Casper; R A Ormsbee; M G Peacock; W Burgdorfer
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

8.  Serological diagnosis of tropical canine pancytopenia by indirect immunofluorescence.

Authors:  M Ristic; D L Huxsoll; R M Weisiger; P K Hildebrandt; M B Nyindo
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

9.  Unexplained febrile illnesses after exposure to ticks. Infection with an Ehrlichia?

Authors:  D B Fishbein; L A Sawyer; C J Holland; E B Hayes; W Okoroanyanwu; D Williams; K Sikes; M Ristic; J E McDade
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

  9 in total
  3 in total

1.  Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis.

Authors:  P Brouqui; C Lecam; J Olson; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

2.  Serologic evidence for human ehrlichiosis in Africa.

Authors:  P Brouqui; C Le Cam; P J Kelly; R Laurens; A Tounkara; S Sawadogo; L Gondao; B Faugere; J Delmont
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

Review 3.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.